HRT and Dementia Risk: What the Research Actually Says
HRT comes up fairly regularly in training and peer support conversations, often prompted by something someone has read online or seen in the news. The research around it is genuinely complex, and headlines have not always helped — swinging between “HRT causes dementia” and “HRT prevents dementia” in ways that leave people more confused than informed.
This post tries to set out what the evidence currently suggests, in plain terms, without overstating what we know or dismissing the questions people are rightly asking.
Why is there a connection between HRT and brain health?
Oestrogen plays a role in brain function — it supports the health of neurons, influences blood flow to the brain, and may have a protective effect on the brain’s memory systems. When oestrogen levels drop during and after menopause, some of these protective effects reduce. This is part of why researchers have explored whether HRT — which replaces some of those hormones — might also affect dementia risk.
The answer, as is often the case in dementia research, is: it depends.
What the research shows
The timing of when HRT is started appears to matter significantly. A study published in Science Advances found that women who began HRT after the age of 60 showed faster accumulation of tau protein in the brain — one of the hallmarks of Alzheimer’s disease. Women who stopped HRT before 60 did not show the same increase in risk. This has given rise to what researchers call the “critical window” or “timing hypothesis” — the idea that HRT started around the onset of menopause may carry different implications for brain health than HRT started later in life.
The type of HRT also appears to make a difference. A large Danish study found a 24% increased rate of dementia among users of combined oestrogen-progestogen therapy, with higher rates linked to longer use. In contrast, oestrogen-only therapy started in midlife has been linked in some studies to around a 32% reduced risk of dementia — though findings vary across studies and populations.
None of this is settled science. The research reflects associations, not certainties, and individual factors — age at menopause, health history, genetics, duration of use — all influence the picture.
What this means practically
For anyone currently using HRT or considering it, the most important thing is to have an informed conversation with your GP. This is not a situation where a blog post should replace medical advice — the individual factors matter too much for a general recommendation to apply to everyone.
What the research does suggest is that timing appears to matter, that not all HRT carries the same risk profile, and that the picture is more nuanced than either the alarming or the reassuring headlines tend to suggest.
For women who are also supporting someone living with dementia, this topic can carry particular personal weight — the question isn’t just academic. If that’s where you are, it’s worth raising it directly with a GP who can look at your individual circumstances rather than relying on population-level findings alone.
Further reading
Alzheimer’s Society — Hormones and dementia risk Science Advances — HRT and tau accumulation BMJ — Menopausal hormone therapy and dementia
Topics like this — understanding what increases or reduces dementia risk, and how to have honest conversations about complex evidence — come up regularly in the Getting to Know Dementia programme. Find out more about the programme and upcoming dates.